![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 11
2017
Barbieri, E.; Gion, M.; Mariani, L.; Stieber, P.; Rubino, D.; Fanti, S.; Baum, R.; Wirtz, R.; Bernardi, A.; Cacciari, N.; Quercia, S.; Lenzi, M.; Cubelli, M.; Pizzirani, C.; Carapelle, M.; Pagliaro, M.; Tomasini, S.; Toracchio, S. und Zamagni, C.
(2017):
Three-monthly dynamic evaluation of CEA and CA15-3 and 18-FDG PET vs usual practice in the follow-up of early breast cancer patients: a prospective, multicenter, randomized trial (KRONOS - Patient-Oriented New Surveillance-Study Italy).
In: Annals of Oncology, Bd. 28
Zamagni, C.; Gion, M.; Mariani, L.; Stieber, P.; Quercia, S.; Rubino, D.; Bernardi, A.; Cacciari, N.; Fini, A.; Lenzi, M.; Minichillo, S.; Pizzirani, C.; Pagliaro, M.; Tomasini, S. und Barbieri, E.
(2017):
Three-monthly dynamic evaluation of CEA and CA15-3 (followed by 18-FDG PET) vs usual practice in the follow-up of early breast cancer (BC) patients (pts): A prospective randomized trial (KRONOS-patient-oriented new surveillance study, Italy).
In: Cancer Research, Bd. 77
2013
Graser, A.; Melzer, A.; Lindner, E.; Nagel, D.; Herrmann, K.; Stieber, P.; Schirra, J.; Mansmann, Ulrich; Reiser, M. F.; Göke, Burkhard und Kolligs, F. T.
(2013):
Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
In: Gastroenterology, Bd. 144, Nr. 4, 743-750 e2
2011
Herbst, A.; Rahmig, K.; Stieber, P.; Philipp, A.; Jung, A.; Ofner, A.; Crispin, Alexander; Neumann, J.; Lamerz, R. und Kolligs, F. T.
(2011):
Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.
In: American Journal of Gastroenterology, Bd. 106, Nr. 6: S. 1110-1118
2010
Boeck, S.; Haas, M.; Laubender, Rüdiger P.; Kullmann, F.; Klose, C.; Bruns, C. J.; Wilkowski, R.; Stieber, P.; Holdenrieder, S.; Buchner, Hannes; Mansmann, Ulrich und Heinemann, V.
(2010):
Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer.
In: Clinical Cancer Research, Bd. 16, Nr. 3: S. 986-994
Haas, M.; Laubender, Rüdiger P.; Stieber, P.; Holdenrieder, S.; Bruns, C. J.; Wilkowski, R.; Mansmann, Ulrich; Heinemann, V. und Boeck, S.
(2010):
Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer.
In: Tumor Biology, Bd. 31, Nr. 4: S. 351-357
2009
Graser, Anno; Stieber, P.; Nagel, D.; Schäfer, C.; Horst, D.; Becker, C.R.; Nikolaou, Konstantin; Lottes, A.; Geisbüsch, Sarah; Kramer, H.; Wagner, A.C.; Diepolder, H.; Schirra, Jörg; Seidel, D.; Göke, Burkhard; Reiser, M.F. und Kolligs, Frank T.
(2009):
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
In: Gut: S. 241-248
[PDF, 704kB]
Herbst, A.; Wallner, M.; Rahmig, K.; Stieber, P.; Crispin, Alexander; Lamerz, R. und Kolligs, F. T.
(2009):
Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
In: European Journal of Gastroenterology & Hepatology, Bd. 21, Nr. 5: S. 565-569
2006
Wallner, M.; Herbst, A.; Behrens, A.; Crispin, Alexander; Stieber, P.; Göke, Burkhard; Lamerz, R. und Kolligs, F. T.
(2006):
Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
In: Clinical Cancer Research, Bd. 12, Nr. 24: S. 7347-7352
2005
Stemmler, H. J.; Stieber, P.; Lässig, D. und Heinemann, Volker
(2005):
Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.
In: Onkologie, Nr. 2: S. 95-97
[PDF, 65kB]
2003
Stemmler, J.; Stieber, P.; Szymala, A. M.; Schalhorn, A.; Schermuly, M. M.; Wilkowski, R.; Helmberger, T.; Lamerz, Rolf; Stoffregen, C.; Niebler, K.; Garbrecht, M. und Heinemann, Volker
(2003):
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
In: Onkologie, Nr. 5: S. 462-467
[PDF, 115kB]